Literature DB >> 50305

Technical aspects of the Haematoxylin--Basic Fuchsin--picric acid (HBFP) stain applied to skeletal muscle.

A T Scherer, A T Masi.   

Abstract

The Haematoxylin-Basic Fuchsin-picric acid (HBFP) stain, a new non-enzymatic histochemical technique described previously to detect early myocardial ischemia, was applied to skeletal muscle. Several factors were found which have an important effect on HBFP positivity including ageing in room air of unstained tissue sections, and the precise timing of the differentiation step of this stain. Using carefully standardized techniques, repeatable staining was obtained and a high level of interobserver consistency in the interpretation of staining results was achieved. Although the technical requirements of this new stain are rigorous, it offers promise and deserves further evaluation in the study of skeletal as well as cardiac muscle disorders. The histological advantages include vivid contrasts and the ability to use the stain on formalin-fixed paraffin-embedded muscle tissue.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50305     DOI: 10.1007/bf01007018

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  12 in total

1.  Histochemical studies of early experimental myocardial infarction; periodic acid-Schiff method.

Authors:  H O YOKOYAMA; R B JENNINGS; G F CLABAUGH; W B WARTMAN
Journal:  AMA Arch Pathol       Date:  1955-03

2.  Histopathology of the Intrinsic Muscles of the Hand in Rheumatoid Arthritis.

Authors:  O C Kestler
Journal:  Ann Rheum Dis       Date:  1949-03       Impact factor: 19.103

3.  Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy.

Authors:  J N Whitaker; W K Engel
Journal:  N Engl J Med       Date:  1972-02-17       Impact factor: 91.245

4.  Letter: Staining techniques.

Authors:  J F Fekete
Journal:  Arch Pathol       Date:  1974-07

5.  Fuchsinophilia and fuchsinorrhagia staining techniques. Use in the early detection of myocardial infarction.

Authors:  F T Zugibe; F T Zugibe
Journal:  Arch Pathol       Date:  1973-10

6.  New histochemical method for morphologic diagnosis of early stages of myocardial ischemia.

Authors:  J T Lie; K E Holley; W R Kampa; J L Titus
Journal:  Mayo Clin Proc       Date:  1971-05       Impact factor: 7.616

7.  Myocardial lesions in anaphylaxis. A histochemical study.

Authors:  C Delage; F G Mullick; N S Irey
Journal:  Arch Pathol       Date:  1973-03

8.  Endothelial inclusions in dermatomyositis.

Authors:  W L Norton; E Velayos; L Robison
Journal:  Ann Rheum Dis       Date:  1970-01       Impact factor: 19.103

9.  Comparison of the microangiopathy of systemic lupus erythematosus, dermatomyositis, scleroderma, and diabetes mellitus.

Authors:  W L Norton
Journal:  Lab Invest       Date:  1970-04       Impact factor: 5.662

10.  Submicroscopic alterations in capillaries of skeletal muscles in polymyositis.

Authors:  A González-Angulo; A Fraga; G Mintz
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

View more
  5 in total

1.  [Early recognition of hypoxic lesions in the cerebellum using Lie staining (HBFP staining)].

Authors:  O Pribilla; M Tönnies
Journal:  Z Rechtsmed       Date:  1983

2.  The Haematoxylin-basic Fuchsin-picric acid staining reaction as a test of myocardial viability in resuscitated and preserved hearts.

Authors:  D K Cooper
Journal:  Histochem J       Date:  1977-05

3.  Exercise preconditioning initiates late cardioprotection against isoproterenol-induced myocardial injury in rats independent of protein kinase C.

Authors:  Yu-Jun Shen; Shan-Shan Pan; Tao Zhuang; Feng-Juan Wang
Journal:  J Physiol Sci       Date:  2010-10-13       Impact factor: 2.781

4.  Heterogeneous staining of rat hepatocyte nuclei by HBFP technique.

Authors:  M A Khan
Journal:  Histochem J       Date:  1978-11

5.  Kudiezi injection mitigates myocardial injury induced by acute cerebral ischemia in rats.

Authors:  Xuemei Liu; Ye Tao; Fengli Wang; Ting Yao; Chen Fu; Hong Zheng; Yan Yan; Xiao Liang; Xiangning Jiang; Yunling Zhang
Journal:  BMC Complement Altern Med       Date:  2017-01-05       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.